XML 61 R45.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 26, 2019
Nov. 18, 2019
Jun. 12, 2019
Apr. 23, 2019
Apr. 22, 2019
Jan. 11, 2019
Apr. 30, 2019
Mar. 31, 2019
Jan. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Number of shares issued during the period, value                     $ 83,000 $ 240,000
Common shares issued for settlement of accounts payable                     238,090  
Common shares issued in conversion of warrants                     $ 120  
Autotelic Inc., [Member]                        
Shares issued price per share                 $ 4.00      
Common shares issued for settlement of accounts payable                 $ 80,772      
Peak One Opportunity Fund, L.P [Member] | Restricted Shares [Member]                        
Number of shares issued during the period   300,000                    
Number of shares issued during the period, value   $ 60,000                    
Shares issued price per share   $ 0.20                    
Conversion percentage   65.00%                    
Conversion maturity date   Jan. 18, 2020                    
Conversion price per share   $ 0.10                    
TFK Investments, LLC [Member] | Restricted Shares [Member]                        
Number of shares issued during the period   300,000                    
Number of shares issued during the period, value   $ 60,000                    
Shares issued price per share   $ 0.20                    
Conversion percentage   65.00%                    
Conversion maturity date   Jan. 08, 2020                    
Conversion price per share   $ 0.10                    
Employee [Member] | Oncotelic [Member]                        
Shares issued price per share           $ 4.00   $ 4.00        
Common shares issued for compensation           $ 11,250   $ 80,594        
Two Separates Investors [Member] | Oncotelic [Member]                        
Number of shares issued during the period                 20,750      
Number of shares issued during the period, value                 $ 83,000      
Shares issued price per share                 $ 4.00      
Two Investors [Member]                        
Common shares issued in conversion of warrants             $ 150,000          
Common shares issued in conversion of warrants, shares             120          
Stock Purchase Agreement [Member] | Oncotelic [Member] | Autotelic Inc., [Member]                        
Number of shares issued during the period 226,988                      
Shares issued price per share $ 4.00                      
Stock Purchase Agreement [Member] | Adhera Therapeutics [Member] | Convertible Series E Preferred Shares [Member] | Autotelic Inc., [Member]                        
Number of shares issued during the period 181.59                      
Number of shares issued during the period, value $ 907,950                      
Stock Purchase Agreement [Member] | Autotelic Inc., [Member]                        
Number of shares issued during the period                   226,988    
Shares issued price per share                   $ 4.00   $ 4.00
Stock Purchase Agreement [Member] | Autotelic Inc., [Member] | Convertible Series E Preferred Shares [Member]                        
Number of shares issued during the period                   181.59    
Number of shares issued during the period, value                   $ 907,950    
Stock Purchase Agreement [Member] | Third-Party Investor [Member] | Oncotelic [Member]                        
Number of shares issued during the period 26,100                      
Stock Purchase Agreement [Member] | Third-Party Investor [Member] | Adhera Therapeutics [Member] | Convertible Series E Preferred Shares [Member]                        
Number of shares issued during the period 20.88                      
Number of shares issued during the period, value $ 104,400                      
Stock Purchase Agreement [Member] | Vuong Trieu [Member] | Oncotelic [Member]                        
Number of shares issued during the period 189,238                      
Shares issued price per share $ 4.00                      
Stock Purchase Agreement [Member] | Vuong Trieu [Member] | Adhera Therapeutics [Member] | Convertible Series E Preferred Shares [Member]                        
Number of shares issued during the period 151.39                      
Number of shares issued during the period, value $ 756,950                      
Merger Agreement [Member]                        
Conversion of shares         10,318,746              
Merger Agreement [Member] | Convertible Debt [Member]                        
Number of restricted stock issued during the period     350,000                  
Merger Agreement [Member] | Series A Preferred Stock [Member]                        
Conversion of shares         0.01877292              
Merger Agreement [Member] | Series A Convertible Preferred Stock [Member]                        
Conversion of shares         0.01877292              
Merger Agreement [Member] | Oncotelic [Member]                        
Conversion of shares         41,000,033              
Merger Agreement [Member] | Oncotelic [Member] | Series A Preferred Stock [Member]                        
Number of shares issued during the period         77,154              
Conversion of shares         193,713              
Merger Agreement [Member] | Oncotelic [Member] | Series A Convertible Preferred Stock [Member]                        
Number of shares issued during the period         77,154              
Conversion of shares       193,713 193,713              
Merger Agreement [Member] | PointR [Member] | Series A Convertible Preferred Stock [Member]                        
Number of shares issued during the period       84,475                
Conversion of shares       11,135,935                
Merger Agreement [Member] | Two Noteholders [Member] | Convertible Debt [Member]                        
Shares issued price per share     $ 0.18 $ 0.11                
Number of restricted stock issued during the period       700,000